PPARG and pulmonary fibrosis: The fact that PPARγ can inhibit fibroblast activation/differentiation and pulmonary fibrosis (48) suggests that KLF4 induction may be a conserved antifibrotic brake that mediates some of the antifibrotic actions of both cAMP-dependent and PPARγ-dependent agonists.